Dong-Chun Lecture : Cell-based High Content Screening (HCS) for action modes of drug targets by using systematic deletion mutants of Schizosaccharomyces pombe

( Dong Uk Kim ),( Im Seon Woo ),( Mi Sun Won ),( Young Joo Jang ),( Kyung Sook Chung ),( Han Oh Park ),( Hyang Sook Yoo ),( Kwang Lae Hoe ),( Doo Sik Kim ) 한국생화학분자생물학회 (구 한국생화학회) 2005 생화학분자생물학회 춘계학술발표논문집 Vol.2005 No.-

물류산업의 국민경제적 파급효과 분석

정동원 ( Dong Won Jeong ),한종호 ( Jong Ho Han ) 한국물류학회 2012 물류학회지 Vol.22 No.2

물류산업은 경제 발전에 중요한 역할을 담당하며, 산업경쟁력과 국가경쟁력을 결정하는 중요한 요소로 작용하고 있다. 본 논문에서는 산업연관분석을 이용하여 물류산업의 국민경제적 파급효과를 분석하고자 한다. 먼저 수요유도형 모형을 이용하여 물류산업의 타 산업 생산유발효과, 부가가치 유발효과, 취업유발효과를 살펴본다. 다음으로 상대적으로 복잡성 때문에 잘 사용되지 않았던 공급유도형 모형 및 레온티에프 가격모형을 적용하여 물류산업의 공급지장효과 및 물가파급 효과를 살펴본다. 이러한 분석은 모두 물류산업을 내생부문이 아닌 외생부문으로 다룸으로써 물류산업을 중심으로 이루어지게 된다. 주요 분석결과를 요약하면 다음과 같다. 물류산업의 1원 생산은 타 산업의 생산을 0.5104원만큼 유발하며, 타산업의 부가가가치를 0.1722원만큼 유발한다. 또한 물류산업의 10억원 생산은 타산업에서 2.2554명의 취업을 유발한다. 한편 물류산업에서 1원의 공급이 이루어지지 못할 때, 타 산업에서는 0.9387원의 생산차질이 발생하여 공급지장효과가 제법 큰 편이다. 마지막으로 물류산업의 가격이 10& 상승했을 때, 국민경제 전체적으로 미치는 물가파급효과는 0.0276%로 분석되었다. The logistics industry in Korea plays a major role in the national economy development and to make decision nation and industrial competitiveness, This study attempts to examine the economic impacts of the logistics industry using an inter-industry analysis, Specially, the study investigates production-inducting effect, value added inducing effect, and employment-inducing effect of the logistics industry based on demand-driven model. Moreover, the study deals with supply shortage effect and sectoral price effect by using supply-driven model and leontief price model, respectively, which have been rarely used because of their complications involved in computaiton. These analyses pay particular and close attention to the distribution industry by taking it as exogenous rather than endogenous. Some interesting findings emerge from the study. First, the production of 1.0 won in the logistics industry induces the production of 0.5104 won and the value-added of 0.1722 won in other industries. Second, the production of 1.0 billion won in the logistics industry causes the employment of 2.554 persons in other industries. Third, the supply shortage of 1.0 won in the logistics industry disables other industries to produce 0.9387 won. Finally, an increase of 10% in price level of the logistics industry raises the overall price level by 0.0276%.

복강경담낭절제술에서 수술전 간담도신티그라피와 경구담낭조영술의 의의

문대혁(Dae Hyuk Moon),양승오(Seoung Oh Yang),이희경(Hee Kyung Lee),원경숙(Kyoung Sook Won),류진숙(Jin Sook Ryu),한동복(Dong Bok Han),박철민(Cheol Min Park),이문규(Moon Gyu Lee),박광민(Kwang Min Park),이승규(Sung Gyu Lee) 대한핵의학회 1997 핵의학 분자영상 Vol.31 No.1

N/A 131I-6β-iodomethyl-19-norcholesterol(NP-59) has an advantage to assess adrenal dysfunction caused by adrenal cortical disorders. The aim of this study is to evaluate the clinical usefulness of NP-59 scintigraphy in each adrenral disease. Ten patients who did eleven NP-59 adrenal scintigraphies at Dong-A University Hospital from March 1990 to December 1996 were selected as the subject. Among the subject there were 5 cases of Cushing's syndrome, 2 cases of incidentaloma, 1 case of metastatic adrenal tumor, liver cirrhosis with hirsutism and hypertension respectively. Among 5 case of Cushing's syndrome, there were 2 cases of Cushing's disease, 2 cases of adrenal adenoma and 1 case of adrenal carcinoma. There are no disagreement between clinical diagnosis and scan finding in Cushing's syndrome. In 2 incidentaloma cases, even though one is interpretated as a functioning tumor, both of 2 cases could avoid unnecessary biopsy according to scintigraphy result. One case of hirsutism, clinically adrenal originated, revealed the normal scintigraphic hirsutism was extra-adrenal origin. One case of hypertension took the study to exclude the possibility of primary aldosteronism. Normal suppression scan finding revealed that primary aldosteronism did not exist in this case. In conclusion, NP-59 scintigraphy was very useful in diagnosis and differential diagnosis of Cushing's syndrome and it could avoid unnecessary biopsy in the incidental adrenal tumor.

기존의 치료에 반응하지 않는 다발성 간전이 대장암 환자에서 방사선조사와 병합한 수지상세포 면역치료의 1, 2상 임상시험

최영민(Youngmin Choi),이형식(Hyung-Sik Lee),권혁찬(Hyuk-Chan Kwon),한상영(Sang-Young Han),최종철(Jong-Cheol Choi),정주섭(Ju-Seop Chung),김창원(Chang-Won Kim),김동원(Dong-Won Kim),강치덕(Chi-Duk Kang) 대한방사선종양학회 2008 Radiation Oncology Journal Vol.26 No.2

목 적: 기존치료에 반응하지 않는 다발성 간전이를 동반한 대장암 환자에서 방사선치료와 병합한 수지상세포 면역 치료의 독성과 반응도를 조사하였다. 대상 및 방법: 2004년 5월부터 2006년 11월까지 다발성 간전이가 동반된 대장암 환자들 중에서 항암화학 요법에 반응하지 않은 환자 중 지원자를 대상으로 연구를 시행하였다. 본 임상 시험에 대하여 동아대학교병원과 부산대학교병원의 임상윤리심의위원회의 허가를 획득하였고, 동의서에 서명한 환자들을 임상 시험의 대상으로 등록하였다. 환자의 말초 혈액으로부터 수지상세포를 추출하여 배양하였다. 임상시험 일자에 맞추어서 6×106개의 수지상세포를 바이알(0.5 ml)에 넣어서 디씨백/아이알 주사를 만들었다. 수지상세포 면역치료는 2주 간격으로 간전이암조직에 3회 주사하고, 5주에 내약성 평가를 하였다. 내약성 평가를 통과한 환자에게는 8주에 4번째 수지상세포 면 역치료를 하였다. 병의 악화가 없거나 임상시험에 대한 환자의 동의 철회가 없는 경우에는 5, 6번째 수지상세포면역치료를 각각 12, 16주에 시행하였다. 방사선치료는 수지상세포 면역치료를 주사할 간전이암 부위에 주사하기 전일 및 당일에 4 Gy씩을 조사하였다. 내약성 평가는 3×106개의 수지상세포로부터 시작하여, 12×106개의 수지상세포까지 시행하였다. 내약성 평가의 최대 내성 용량으로 추가 임상시험을 하였다. 수지상세포 면역치료 주사를 맞은 모든 환자들에서 안전성 평가를 하였다. 4회 이상 주사를 맞은 환자들을 대상으로 10주에 치료 반응을 평가하여 유효성을 조사하였다. 결 과: 임상시험에 등록한 24명 중 22명에서 수지상세포 면역치료를 시행하였다. 내성약 평가에는 14명이 등록하여 11명에서 평가를 완료하였다. 시험약과의 관련성이 있을 것으로 생각되는 grade 3 이상의 약물반응으로 인한 이상반응은 없었다. 12×106개의 수지상세포를 내성용량으로 확인하였고, 내성용량인 12×106개 수지상세포 면역치료를 이용하여 8명에서 추가로 시험을 하였다. 치료에 대한 환자들의 내성은 양호하였고, grade 3을 초과하는 치명적인 부작용은 발생되지 않았다. 4회 이상의 수지상세포 면역치료 주사를 받은 환자가 17명이었고, 이 중의15명에서는 종양의 반응도 평가가 이루어졌다. 본 연구의 목적은 안전성 평가이지만, 면역치료의 유효성 평가를 위해, 방사선치료와 수지상세포 면역치료 주사가 시행된 부위 외의 간전이암에서 반응도를 조사 하였다. 면역치료의 반응은 평가가 이루어진 환자들에서 정지성 병변이 4명, 진행성 병변이 11명 이었다. 결 론: 수지상세포 면역치료와 병행한 방사선치료는 이론적으로 국소 및 전신 제어에 상승효과가 있을 것으로 기대할 수 있다. 하지만 기존 치료에 반응하지 않는 매우 진행된 직장암 환자들을 대상으로 한 본 연구에서는 방사선 치료와 병합한 수지상세포 면역치료로 인한 심각한 부작용의 발생은 없었다는 결과와 4예에서의 정지성 병변의 관찰을 보고한다. 수지상세포의 최대 투여 용량, 적절한 투여 방법, 적절한 방사선의 양, 방사선과 수지상 세포의적절한 투여 간격 등에 관한 추가 연구를 통하여, 향후 제 2상, 3상 시험으로서의 진행 여부에 긍정적인 결과를얻을 수 있다고 판단한다. Purpose: To assess the toxicity and tumor response induced by DCVac/IRⓇ dendritic cell (DC) immunotherapy combined with irradiation for refractory colorectal cancer patients with multiple liver metastases. Materials and Methods: Between May 2004 and November 2006, applicants from a pool of refractory colorectal cancer patients with multiple liver metastases were enrolled. The patients were registered after having signed the informed consent form, which had been approved by the Institutional Review Board from the Dong-A University and Busan National University Hospital. DCs were obtained from peripheral blood of each patient, and then cultured in vitro. A total of 6×106 DCs were packed into a vial (DCVac/IRⓇ, 0.5 ml) at the convenience of each patient’s schedule. On the day before and on the day of each vaccination, each patient received a 4 Gy radiation dose to the target tumor. On the day of vaccination, the indicated dose of autologous DCs was injected into the irradiated tumor using ultrasound-guided needle injection procedures. A total of four vaccinations were scheduled at three 2-week intervals and one 4 week interval at the Dong-A University and Busan National University Hospital. If the tumor status was deemed to be stable or responding to therapy, an additional vaccination dose or two was approved at 4 week intervals beyond the fourth immunization. A tolerance test for DCs was conducted by injecting a range of doses (3×106 to 12×106 DCs) after the 3rd injection. Moreover, the maximal tolerable dose was applied to additional patients. Treatment safety was evaluated in all patients who had at least one injection. Treatment feasibility was evaluated by the 10th week by assessing the response of patients having at least 4 injections. For systemic toxicities, the evaluation was performed using the National Cancer Institute Common Toxicity Criteria, whereas adverse effects were recorded using common WHO toxicity criteria. Results: Of the 24 registered patients, 22 received the DCs injections. Moreover, of the 14 patients that applied for the tolerance test, only 11 patients completed it because 3 patients withdrew their testing agreement. A grade 3 or more side effect, which was possibly related to the DC injection, did not occur in additional patients. The 12×106 DC injection was identified as the maximum tolerable dose, and was then injected in an additional 8 patients. Patients tolerated the injection fairly well, with no fatal side effects. In order to assess the feasibility of DC immunotherapy, the response was evaluated in other hepatic lesions outside of the targeted hepatic lesion. The response evaluation was performed in 15 of the 17 patients who received at least 4 injections. Stable and progressive disease was found in 4 and 11 patients, respectively. Conclusion: The DC-based immunotherapy and radiotherapy is theoretically synergistic for the local control and systemic control. The DCVac/IRⓇ immunotherapy combined with irradiation was tolerable and safe in the evaluated cases of refractory colorectal cancer with multiple liver metastases. Future work should include well designed a phase II clinical trials

HO-1 Induction by <i> Selaginella tamariscina</i> Extract Inhibits Inflammatory Response in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages

Won, An-Na,Kim, Sun Ah,Ahn, Jung Yun,Han, Jae-Hyun,Kim, Chang-Hyun,Lee, Ju-Hee,Kim, Dong-Il Hindawi 2018 Evidence-based Complementary and Alternative Medic Vol.2018 No.-

<P><I>Selaginella Herba</I> is the dried, aerial part of<I> Selaginella tamariscina </I>(P.Beauv.) Spring and has been used to treat amenorrhea, abdominal pain, headaches, and hematuria in Korea. However, scientific evidence regarding the anti-inflammatory activity and action mechanism of<I> Selaginella tamariscina</I> is lacking. Thus, the present study was performed to investigate the anti-inflammatory and antioxidant activities of<I> Selaginella tamariscina</I> ethanol extract (STE) against lipopolysaccharide (LPS)-induced inflammatory responses and identify the molecular mechanism responsible. STE was prepared by heating in 70% ethanol and its quality was confirmed by HPLC. STE dose-dependently inhibited the productions of inflammatory mediators (NO and PGE<SUB>2</SUB>) and proinflammatory cytokines (IL-1<I>β</I> and IL-6) in LPS-stimulated RAW 264.7 cells. STE markedly suppressed the phosphorylations of MAPKs, I<I>κ</I>B-<I>α</I>, and NF-<I>κ</I>B and the nuclear translocation of NF-<I>κ</I>B induced by LPS stimulation. In addition, STE exhibited good free radical scavenging activity and prevented ROS generation by LPS. STE also upregulated the expression of Nrf2 and HO-1 and promoted the nuclear translocation of Nrf2. Taken together, STE was found to have anti-inflammatory and antioxidant effects on RAW 264.7 macrophages and the mechanism appeared to involve the MAPK, NF-<I>κ</I>B, and Nrf2/HO-1 signaling pathways. These results suggest that STE might be useful for preventing or treating inflammatory diseases and provide scientific evidence that supports the developments of herbal prescriptions or novel natural products.</P>

A Design and Implementation of Communication Simulator Using C++

Han Kyung Kim,Sang Kook Jeong,Dong Won Jang,Kwang Hui Lee,Jong Kun Lee 대한전자공학회 1998 ITC-CSCC :International Technical Conference on Ci Vol.- No.-

Study on the Anatomical Position of Mandibular Canal Using Computed Tomography in Mandibular Prognathism Patients

Dong Hyun Lee,Jae Won Kim,Su Youn Lee,Jae Hyun Kim,Sang Heon An,Sang Han Lee,Hyun Jung Jang 大韓顎顔面成形再建外科學會 2009 Maxillofacial Plastic Reconstructive Surgery Vol.31 No.2S

Effects of social supports on burden in caregivers of people with dementia

Han, Ji Won,Jeong, Hyeon,Park, Jae Young,Kim, Tae Hui,Lee, Dong Young,Lee, Dong Woo,Ryu, Seung-Ho,Kim, Shin-Kyeom,Yoon, Jong Chul,Jhoo, JinHyeong,Kim, Jeong Lan,Lee, Seok Bum,Lee, Jung Jae,Kwak, Kyung Cambridge University Press 2014 INTERNATIONAL PSYCHOGERIATRICS - Vol.26 No.10

<B>ABSTRACT</B><B>Background:</B><P>Social support programs for dementia caregivers were widely used in order to reduce care burden. We investigated which types of social supports can reduce psychological and non-psychological burdens of dementia caregivers, and explored the mechanism of those social supports.</P><B>Methods:</B><P>We evaluated 731 community-dwelling dementia patients and their caregivers from the National Survey of Dementia Care in South Korea. We investigated the five types of social supports (emotional support, informational support, tangible support, positive social interaction, affectionate support) using the Medical Outcomes Study Social Support Survey in each caregiver. The mechanisms of specific types of social support on psychological/non-psychological burden were examined using path analysis.</P><B>Results:</B><P>Positive social interaction and affectionate support reduced psychological burden via direct and indirect paths. Tangible support reduced the non-psychological burden via direct and indirect paths. Informational support and emotional support were not helpful for reducing psychological or non-psychological burden. A maximum of 20% of psychological burden could be relieved by positive social interaction and 10.3% of that could be reduced by affectionate support. Tangible support was associated with a 15.1% maximal improvement in non-psychological burden.</P><B>Conclusions:</B><P>In order to reduce caregiver burden in dementia effectively, psychosocial interventions should be tailored to target type of caregiver burden.</P>

Plenary Session 1 : PS-1-2 ; Ultrasonographically detected nonalcoholic fatty liver disease combined with serum gamma- glutamyltransferase predicts the risk of cardiovascular disease in individuals without metabolic syndrome

( Dong Hyun Sinn ),( Geum Youn Gwak ),( Da Min Kim ),( Jee Eun Kim ),( Yang Won Min ),( Yong Han Paik ),( Moon Seok Choi ),( Joon Hyeok Lee ),( Kwang Cheol Koh ),( Seung Woon Paik ),( Byung Chul Yoo ) 대한간학회 2012 춘·추계 학술대회 (KASL) Vol.2012 No.-

Background: Individuals with nonalcoholic fatty liver disease (NAFLD) have an increased risk of cardiovascular diseaserelated morbidity and mortality. However, as NAFLD share common risk factors with metabolic syndrome, and as metaboilc syndrome is closely related to cardiovascular disease-related morbidity and mortality, it remains unclear whether NAFLD serves as an independent predictor for developing cardiovascular disease. We assessed whether ultrasonographically detected-NAFLD (US-NAFLD) can help identify individuals at an increased risk of cardiovascular disease in metabolic syndromefree individuals. Methods: A total of 4,639 metabolic syndrome-free health check-up participants (age = 53.2 ± 9.4, male = 3,856 (83.1%)) who had abdominal ultrasonography and carotid artery ultrasonography were analyzed. Carotid plaque, known as an early predictor for developing cardiovascular disease, was assessed and defined when intima-media thickness > 1.5 mm in any carotid segment. Results: US-NAFLD was noticed in 1,770 (38.2%) individuals, and carotid plaque was more prevalent in individuals with NAFLD than without NAFLD (48.5% vs. 38.4%, p<0.001). US-NAFLD was independently associated with the presence of carotid plaque [adjusted odd ratio (95% confidence interval): 1.63 (1.42 - 1.87), p<0.001, adjusted for age, each component of metabolic syndrome, and serum gamma-glutamyltransferase (GGT) level]. US-NAFLD combined with serum GGT level showed a fine correlation with the presence of carotid plaque in both young (<50 years, 34.8%, 26.5%, 22.4% and 19.2% for individuals with US-NAFLD/GGT (+/+),US-NAFLD/ GGT (+/-), US-NAFLD/GGT (-/+) and US-NAFLD/GGT (-/-), respectively) and old people (≥ 50 years, 61.7%, 59.9%, 54.2% and 45.3% for individuals with US-NAFLD/GGT (+/+), USNAFLD/ GGT (+/-), US-NAFLD/GGT (-/+) and US-NAFLD/ GGT (-/-) respectively). Conclusions: US-NAFLD combined with serum GGT level predicts the risk of cardiovascular disease in individuals without metabolic syndrome.

Free Paper Session : HCC ; Useful serum oncomarkers predicting radiological response and survival outcome in patients with hepatocellular carcinoma undergoing transarterial chemoembolization (초)

( Won Hyeong Park ),( Ju Hyun Shim ),( Young Joo Jin ),( Dan Bi Lee ),( Kang Mo Kim ),( Young Suk Lim ),( Han Chu Lee ),( Young Hwa Chung ),( Yung Sang Lee ),( Dong Jin Suh ) 대한간학회 2011 Clinical and Molecular Hepatology(대한간학회지) Vol.17 No.3(S)